Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

Date: 2016-03

“Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets
Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the stomach with Helicobacter pylori may lead to inflammation (known as chronic atrophic gastritis) and pre-cancerous changes to the inner lining of the stomach.
This report provides the current incident population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Argentina, Australia, Canada, Russian, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the classifications and co-morbidities of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main features and co-morbidities associated with Stomach Cancer include:
• History of stomach polyps or stomach lymphoma
• Family history of stomach cancer
• Colorectal cancer
• Familial adenomatous polyposis
• BRCA1/BRCA2 mutations
• Megaloblastic (pernicious) anaemia or being blood type A
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Stomach Cancer’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer’s incident population.
• Identify sub-populations within Stomach Cancer which require treatment.
• Gain an understanding of the specific markets that have the largest number of Stomach Cancer patients.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample